Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> > >

Purdue Pharma offers $10 billion-$12 billion to settle opioid claims: NBC

Reuters Tuesday, 27 August 2019
OxyContin maker Purdue Pharma and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion, NBC News reported on Tuesday citing two people familiar with the mediation.
0
shares
ShareTweetSavePostSend
 
Credit: Rumble - Published < > Embed
News video: Purdue in talks for multibillion dollar opioid settlement

Purdue in talks for multibillion dollar opioid settlement 01:01

OxyContin maker Purdue Pharma and its owners, the Sackler family, is in discussion to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion, two people familiar with the matter said on Tuesday. Jillian Kitchener has more.

Recent related videos from verified sources

Purdue University wants to remind the public they are not affiliated with Purdue Pharma [Video]Purdue University wants to remind the public they are not affiliated with Purdue Pharma

Purdue Pharma has been a subject of controversy recently due to to its role in the Opioid crisis and Purdue University is taking steps to prevent confusion between the university and the company.

Credit: WLFIPublished

Purdue Pharma's Bankruptcy Move Draws Criticism Amid Ongoing Opioid Epidemic [Video]Purdue Pharma's Bankruptcy Move Draws Criticism Amid Ongoing Opioid Epidemic

Purdue Pharma, the company behind the prescription painkiller OxyContin, has filed for bankruptcy. The filing comes days after it reached a settlement with more than 20 states which blame Purdue for..

Credit: CBS 2 New York     Duration: 02:20Published


Recent related news from verified sources

The Latest: Purdue Pharma proposes $200M for opioid crisis

The Latest on the Purdue Pharma's bankruptcy case (all times local): 10:50 a.m. Purdue Pharma has agreed to advance $200 million to battle the opioid...
SeattlePI.com

OxyContin maker Purdue gets brief shield from litigation

OxyContin maker Purdue Pharma LP won a court order on Friday briefly pausing the sprawling opioid litigation against the company so it can try to make headway on...
Reuters

You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.